Gemphire Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch GEMP and buy or sell other stocks, ETFs, and their options commission-free!

About GEMP

Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. 

CEO
Steve Gullans, PhD
CEOSteve Gullans, PhD
Employees
9
Employees9
Headquarters
Livonia, Michigan
HeadquartersLivonia, Michigan
Founded
2014
Founded2014
Employees
9
Employees9

GEMP Key Statistics

Market cap
25.10M
Market cap25.10M
Price-Earnings ratio
-0.19
Price-Earnings ratio-0.19
Dividend yield
Dividend yield
Average volume
73.85K
Average volume73.85K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$5.16
52 Week high$5.16
52 Week low
$0.63
52 Week low$0.63
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.